Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus Survey
Overview
Pharmacology
Public Health
Authors
Affiliations
Background: Resource use measurement by patient recall is characterized by inconsistent methods and a lack of validation. A validated standardized resource use measure could increase data quality, improve comparability between studies, and reduce research burden.
Objectives: To identify a minimum set of core resource use items that should be included in a standardized adult instrument for UK health economic evaluation from a provider perspective.
Methods: Health economists with experience of UK-based economic evaluations were recruited to participate in an electronic Delphi survey. Respondents were asked to rate 60 resource use items (e.g., medication names) on a scale of 1 to 9 according to the importance of the item in a generic context. Items considered less important according to predefined consensus criteria were dropped and a second survey was developed. In the second round, respondents received the median score and their own score from round 1 for each item alongside summarized comments and were asked to rerate items. A final project team meeting was held to determine the recommended core set.
Results: Forty-five participants completed round 1. Twenty-six items were considered less important and were dropped, 34 items were retained for the second round, and no new items were added. Forty-two respondents (93.3%) completed round 2, and greater consensus was observed. After the final meeting, 10 core items were selected, with further items identified as suitable for "bolt-on" questionnaire modules.
Conclusions: The consensus on 10 items considered important in a generic context suggests that a standardized instrument for core resource use items is feasible.
A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist.
Ride J, Goranitis I, Meng Y, LaBond C, Lancsar E Pharmacoeconomics. 2024; 42(10):1161-1175.
PMID: 39227559 PMC: 11405421. DOI: 10.1007/s40273-024-01431-6.
Dennett R, Thompson T, Clyne W, Straukiene A, Davies-Cox H, Hosking J BMJ Open. 2024; 14(8):e087020.
PMID: 39160107 PMC: 11337699. DOI: 10.1136/bmjopen-2024-087020.
Morgan C, Donaldson C, Lancsar E, Petrou S, Andronis L Pharmacoeconomics. 2024; 42(11):1267-1277.
PMID: 39153138 PMC: 11499441. DOI: 10.1007/s40273-024-01411-w.
Lower urinary tract symptoms in men: the TRIUMPH cluster RCT.
Worthington J, Frost J, Sanderson E, Cochrane M, Wheeler J, Cotterill N Health Technol Assess. 2024; 28(13):1-162.
PMID: 38512051 PMC: 11017146. DOI: 10.3310/GVBC3182.
Garfield K, Thornton G, Husbands S, Cameron A, Hollingworth W, Noble S Pharmacoecon Open. 2024; 8(3):431-443.
PMID: 38453803 PMC: 11058127. DOI: 10.1007/s41669-024-00479-6.